Ertugliflozin
Therapeutic Group
Blood Glucose Lowering Drugs, Excluding InsulinIndication Dosage
Ertugliflozin is a medication used to treat type 2 diabetes mellitus. It belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. Ertugliflozin helps lower blood sugar levels by promoting the excretion of excess glucose through urine.
Dosage:
The standard starting dose for most patients is 5 mg once daily, taken by mouth with or without food.
Content
- Tab 5mg/15mg: Ertugliflozin 5mg/15mg
Pregnancy
Contraindicated in Pregnancy
Stability
- Sodium-glucose Co-Transporter 2 (SGLT2) Inhibitors
Contra Indications
- Diabetic Ketoacidosis, Severe Heart Failure, Severe Hepatic Impairment.
Precautions
- Diabetic Ketoacidosis, Severe Heart Failure, Severe Hepatic Impairment.
Lactation
- Contraindicated or Not Recommended
Side Effects
- Urinary tract infections
- Genital yeast infections
- Increased urination
- Dehydration
- Increased cholesterol levels
- Ketoacidosis (rarely)
- Orthostatic hypotension
- Increased serum creatinine levels.